ARCUTIS BIOTHERAPEUTICS INC's ticker is ARQT and the CUSIP is 03969K108. A total of 136 filers reported holding ARCUTIS BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 4.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $78,041 | -43.9% | 14,697 | +0.7% | 0.00% | – |
| Q2 2023 | $139,109 | -8.3% | 14,597 | +5.9% | 0.00% | – |
| Q1 2023 | $151,657 | -25.7% | 13,787 | 0.0% | 0.00% | – |
| Q4 2022 | $204,048 | -22.4% | 13,787 | 0.0% | 0.00% | -100.0% |
| Q3 2022 | $263,000 | -10.5% | 13,787 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $294,000 | +34.9% | 13,787 | +72.9% | 0.00% | – |
| Q2 2021 | $218,000 | – | 7,976 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 8,684,232 | $165,956,000 | 12.78% |
| Bain Capital Life Sciences Investors, LLC | 3,000,000 | $57,330,000 | 6.84% |
| Pivotal bioVenture Partners Investment Advisor LLC | 569,041 | $10,874,000 | 3.97% |
| Logos Global Management LP | 1,525,000 | $29,143,000 | 3.58% |
| 1492 Capital Management LLC | 178,320 | $3,408,000 | 2.45% |
| Cormorant Asset Management, LP | 1,000,000 | $19,110,000 | 1.34% |
| MPM BioImpact LLC | 257,185 | $4,915,000 | 1.16% |
| Orbimed Advisors | 2,800,000 | $53,508,000 | 0.99% |
| SECTORAL ASSET MANAGEMENT INC | 220,985 | $4,223,000 | 0.83% |
| Rubric Capital Management LP | 472,047 | $9,021,000 | 0.45% |